UK markets closed
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • FTSE 250

    18,636.98
    -29.80 (-0.16%)
     
  • AIM

    875.21
    -1.01 (-0.12%)
     
  • GBP/EUR

    1.1593
    -0.0018 (-0.16%)
     
  • GBP/USD

    1.2103
    -0.0072 (-0.59%)
     
  • BTC-GBP

    15,902.66
    -28.28 (-0.18%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • DOW

    31,097.26
    +321.83 (+1.05%)
     
  • CRUDE OIL

    108.46
    +2.70 (+2.55%)
     
  • GOLD FUTURES

    1,812.90
    +5.60 (+0.31%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     
  • HANG SENG

    21,859.79
    -137.10 (-0.62%)
     
  • DAX

    12,813.03
    +29.26 (+0.23%)
     
  • CAC 40

    5,931.06
    +8.20 (+0.14%)
     

Global Vascular Grafts Market to Reach US$4.4 Billion by the Year 2026

·28-min read
ReportLinker
ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, June 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Grafts Industry" - https://www.reportlinker.com/p05896475/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Vascular Grafts Market to Reach US$4.4 Billion by the Year 2026

Vascular grafts are implants that are used during surgical procedures that involve peripheral vessel bypass or aortic repair. They are synthetic tubes that are surgically implanted in the arteries and veins to repair diseased or injured areas in the arteries. Vascular grafts are also used to patch up whole segments of the aorta and other larger arteries. By harnessing the vascular grafts, damaged or diseased blood vessels are replaced or patched up to redirect the blood flow. Vascular grafts come in an array of materials, such as biosynthetic, polyester, polyurethane, and polytetrafluoroethylene (ePTFE). While vascular grafts are largely used in the heart during a coronary artery bypass, they are also deployed to treat renal failure, vascular occlusion, vascular disease, and aneurysm. The increasing prevalence of diabetes, hypertension, vascular occlusions, end-stage renal disease, and peripheral artery diseases has been a growth driver for the vascular graft treatment market. There is greater public awareness of coronary diseases brought about by sedentary lifestyles, unhealthy eating habits, and smoking. Vascular grafts are also deployed for kidney transplants for repairing renal vessels.

Amid the COVID-19 crisis, the global market for Vascular Grafts estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is projected to grow at a 6.2% CAGR to reach US$2.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Vascular Repair segment is readjusted to a revised 8% CAGR for the next 7-year period. This segment currently accounts for a 32.7% share of the global Vascular Grafts market. The endovascular grafts dominated market share, fueled by the surging demand for sophisticated endovascular grafts. Anaconda AAA Stent Graft System of Terumo and Endurant II AAA Stent Graft System of Medtronic are the main products in the market. Increasing R&D and new product introductions are expected to foster market growth.

The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $486.7 Million by 2026

The Vascular Grafts market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.2% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$486.7 Million in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$213.4 Million by the end of the analysis period.

Hemodialysis Access Segment to Reach $876 Million by 2026

The hemodialysis vascular graft market has been registering healthy demand, attributed to the growing prevalence of kidney diseases worldwide. Further, the rising use of biological access products on account of technological developments is also driving market growth. Rising number of patients with renal impairment and low availability of kidney donors are encouraging hemodialysis procedures in such patients, which is boosting market prospects. In the global Hemodialysis Access segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$590.8 Million in the year 2020 will reach a projected size of US$793.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.9 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period.
Select Competitors (Total 44 Featured) -

  • Abbott Laboratories

  • B. Braun Melsungen AG

  • Bard Peripheral Vascular Inc.

  • Cardinal Health, Inc.

  • Cook Medical

  • CryoLife, Inc.

  • ENDOLOGIX LLC.

  • Getinge AB

  • W. L. Gore & Associates, Inc.

  • LeMaitre Vascular, Inc.

  • Medtronic plc

  • Terumo Corporation




Read the full report: https://www.reportlinker.com/p05896475/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vascular Grafts - Global Key Competitors Percentage Market
Share in 2022 (E)
A Prelude to Vascular Grafting
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
COVID-19 and Vascular Grafts Market
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
Impact of COVID-19 Outbreak on Elective Surgeries
Global Market Prospects and Overview
Vascular Grafts Market Set for a Rapid Growth
Endovascular Stent-Grafts Account for Larger Share
Competition
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Increasing Incidence of Cardio Vascular Disease Bodes Well for
the Global Vascular Graft Market
Fatalities by Heart Conditions: Estimated Percentage Breakdown
for Cardiovascular Disease, Ischemic Heart Disease, Stroke,
and Others
Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Rising Preference for Minimally Invasive Procedures Boosts
Market Prospects
Rising Prevalence of Kidney Diseases Drives the Global
Hemodialysis Vascular Graft Market
Hemodialysis Remains the Major Modality for Dialysis Treatment -
A Key Opportunity
Global Dialysis Patient Population Distribution by Modality for
Select Countries (2020): Percentage Breakdown of Hemodialysis
(HD) and Peritoneal Dialysis (PD) Patients
Global Population of ESRD Patients Undergoing Therapy by Type
of Treatment (2020): Percentage Breakdown of Patients
Receiving Hemodialysis, Kidney Transplants, and Peritoneal
Dialysis
Home Hemodialysis: A Niche Albeit High Potential Market
World Dialysis Clinics Market by Region (2019): Percentage
Breakdown of Patients Treated by Type of Operator
Global Dialysis Market by Region: Percentage Breakdown of
Patients Receiving Dialysis Treatment in In-Centre and Home
Settings for 2019
Aging Population Drives Demand for Vascular Grafts
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years
2016 & 2018
Rising Middle Class Population Aids Growth
Global Middle Class Population (in Millions) and as a
Percentage of Total Population: 2005, 2015, 2025 & 2035
Global Middle Class Spending (in US$ Trillion) by Geographic
Region
Risk of CAD in Obesity Offers Prospects for Coronary Stenting
Obesity Prevalence Rate (%) in Select Countries for the Years
2019 and 2030P
Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular
Remodeling
Cells for Cells Develops VEINTIS?
New Approach for Optimizing TEVGs
3D Printed Vascular Scaffolds Hold Potential to be the New-Age
TEVGs
A Review of Select Vascular Developments
Some of the important vascular innovations expected in the
near-term include:
Offerings of Moving Analytics and Vasctrac

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Endovascular Aneurysm Repair
(EVAR) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Endovascular Aneurysm
Repair (EVAR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Peripheral Vascular Repair by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Peripheral Vascular Repair
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Peripheral Vascular
Repair by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 7: World Recent Past, Current & Future Analysis for
Hemodialysis Access by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Hemodialysis Access by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Hemodialysis Access by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Polyester by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Polyester by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Polyester by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
ePTFE by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for ePTFE by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for ePTFE by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Polyurethane by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Polyurethane by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Polyurethane by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Biosynthetic by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Biosynthetic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Biosynthetic by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Ambulatory Surgical Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 28: World Recent Past, Current & Future Analysis for
Vascular Grafts by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Vascular Grafts by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Vascular Grafts by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2022 (E)
Table 31: USA Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Vascular Grafts by Indication -
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular
Repair and Hemodialysis Access Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: USA 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 34: USA Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 35: USA Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 37: USA Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 39: USA 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

CANADA
Table 40: Canada Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: Canada 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 43: Canada Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 44: Canada Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 46: Canada Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

JAPAN
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2022 (E)
Table 49: Japan Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 51: Japan 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 52: Japan Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 53: Japan Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 55: Japan Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

CHINA
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2022 (E)
Table 58: China Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 60: China 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 61: China Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 62: China Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 64: China Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

EUROPE
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2022 (E)
Table 67: Europe Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: Europe 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 70: Europe Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 71: Europe Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 73: Europe Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

Table 76: Europe Recent Past, Current & Future Analysis for
Vascular Grafts by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 77: Europe Historic Review for Vascular Grafts by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Vascular Grafts by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

FRANCE
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2022 (E)
Table 79: France Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: France 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 82: France Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 83: France Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 85: France Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

GERMANY
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2022 (E)
Table 88: Germany Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 90: Germany 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 91: Germany Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 92: Germany Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Vascular Grafts by
Raw Material - Percentage Breakdown of Value Sales for
Polyester, ePTFE, Polyurethane and Biosynthetic for the Years
2012, 2021 & 2027

Table 94: Germany Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Vascular Grafts by
End-Use - Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

ITALY
Table 97: Italy Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 99: Italy 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 100: Italy Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 101: Italy Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 103: Italy Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

UNITED KINGDOM
Vascular Grafts Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2022 (E)
Table 106: UK Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Vascular Grafts by Indication -
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular
Repair and Hemodialysis Access Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 108: UK 15-Year Perspective for Vascular Grafts by
Indication - Percentage Breakdown of Value Sales for
Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair
and Hemodialysis Access for the Years 2012, 2021 & 2027

Table 109: UK Recent Past, Current & Future Analysis for
Vascular Grafts by Raw Material - Polyester, ePTFE,
Polyurethane and Biosynthetic - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 110: UK Historic Review for Vascular Grafts by Raw
Material - Polyester, ePTFE, Polyurethane and Biosynthetic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Vascular Grafts by Raw
Material - Percentage Breakdown of Value Sales for Polyester,
ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 &
2027

Table 112: UK Recent Past, Current & Future Analysis for
Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 113: UK Historic Review for Vascular Grafts by End-Use -
Hospitals and Ambulatory Surgical Centers Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 114: UK 15-Year Perspective for Vascular Grafts by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

SPAIN
Table 115: Spain Recent Past, Current & Future Analysis for
Vascular Grafts by Indication - Endovascular Aneurysm Repair
(EVAR), Peripheral Vascular Repair and Hemodialysis Access -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Vascular Grafts by
Indication - Endovascular Aneurysm Repair (EVAR), Peripheral
Vascular Repair and Hemodialysis Access Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 117: Spain 15-Year Perspective for Vascular Grafts by

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896475/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting